# Efficacy and Safety of the Combination of Acetylcysteine, Paracetamol and Phenylephrine for the Treatment of Common Cold

> **NCT05070650** · PHASE3 · WITHDRAWN · sponsor: **Sandoz**

## Conditions studied

- Common Cold

## Interventions

- **DRUG:** Acetylcysteine
- **DRUG:** Paracetamol
- **DRUG:** Phenylephrine

## Key facts

- **NCT ID:** NCT05070650
- **Lead sponsor:** Sandoz
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2024-09-20
- **Primary completion:** 2025-04-30
- **Final completion:** 2025-04-30
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Sandoz has decided to withdraw the clinical study due to internal business reasons. No patients were enrolled in any of the participating countries.
- **Last updated:** 2024-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05070650

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05070650, "Efficacy and Safety of the Combination of Acetylcysteine, Paracetamol and Phenylephrine for the Treatment of Common Cold". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05070650. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*